Hematopoietic stem cells for transplantation

Nature Immunology

Volumn 3, Issue 4, 2002, Pages 314-317

  Verfaillie, Catherine M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD34 ANTIGEN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FAS ANTIGEN; GLYCOSAMINOGLYCAN; GRANULOCYTE COLONY STIMULATING FACTOR; HOMEODOMAIN PROTEIN; NOTCH RECEPTOR; PROTEIN BCL 2; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; BONE MARROW CELL; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NOTE; ONTOGENY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0036222413     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0402-314     Document Type: Note

References (99)

1. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
2. + cells identifies a population of functional endothelial precursors
3. Isolation of putative progenitor endothelial cells for angiogenesis
4. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro
5. + hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution
6. + human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells
7. Long-term lymphohematopoietic reconstitution by a single 34-low/negative hematopoietic stem cell
8. Reversible expression of CD34 by murine hematopoietic stem cells
9. Development changes of CD34 expression by murine hematopoietic stem cells
10. A newly discovered class of human hematopoietic cells with SCID-repopulating activity
11. - Hematopoietic cells
12. + cells from bone marrow
13. + stem cell transplantation
14. AC133, a novel marker for human hematopoietic stem and progenitor cells
15. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
16. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
17. + side population (SP)phenotype
18. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
19. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells
20. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells
21. Bone marrow transplantation with interleukin-1 plus kitligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential
22. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts
23. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo
24. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
25. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population
26. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro
27. + subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures
28. Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers
29. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors
30. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo
31. null) NOD/SCID mice are excellent recipients for studying human stem cell function
32. An in vivo competition repopulation assay for various sources of human hematopoietic stem cells
33. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin-null mice
34. Long-term persistence of canine hematopoietic cells genetically marked by retro-virus vectors
35. Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells
36. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts
37. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver
38. Age-associated characteristics of murine hematopoietic stem cells
39. In vitro self-renewal division of hematopoietic stem cells
40. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow
41. The aging of lympho-hematopoietic stem cells
42. Peripheral blood stem cell versus bone marrow allotransplantation: Does the source of hematopoietic stem cells matter?
43. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor
44. Characterization of primitive hematopoietic cells in normal human peripheral blood
45. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant
46. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor
47. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo
48. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs
49. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in non-human primates
50. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients
51. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood
52. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo
53. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer
54. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer
55. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells
56. Ex vivo expansion of hematopoietic progenitor cells and mature cells
57. Ex-vivo expansion of hematopoietic progenitor cells: Preliminary results in breast cancer
58. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients
59. + hematopoietic progenitors
60. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens
61. + cells isolated in subcompartments of the G0/G1 phase of the cell cycle
62. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit
63. Cell cycle activation of hematopoietic progenitor cells increases very lateantigen-5-mediated adhesion to fibronectin
64. 0
65. - cells fractionated on the basis of adhesion molecule expression and position in cell cycle
66. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95)
67. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential
68. + cord blood cells is linked to apoptosis after growth factor withdrawal
69. Stochastic model revisited
70. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo
71. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation
72. Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad-mesonephros region-derived endothelium
73. Functional heterogeneity of the hematopoietic microenvironment rare stromal elements maintain long-term repopulating stem cells
74. A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis
75. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow
76. Microenvironmental regulation of hematopoietic stem cells
77. The human homologue of rat Jagged I expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch I
78. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
79. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
80. + cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
81. -/low cells capable of repopulating severe combined immunodeficiency mice
82. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
83. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
84. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation
85. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines
86. Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haemopoiesis
87. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche
88. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells
89. Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo
90. LIN-12/Notch signaling: Lessons from worms and flies
91. The notch ligand jagged-I represents a novel growth factor of human hematopoietic stem cells
92. The Notch ligand jagged-I influences the development of primitive hematopoietic precursor cells
93. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs
94. The genetic program of hematopoietic stem cells
95. From hematopoiesis to neuropoiesis: Evidence of overlapping genetic programs
96. Multilineage development from adult bone marrow cells
97. Hematopoiesis and stem cells: Plasticity versus developmental heterogeneity
98. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo
99. Identification of a candidate human neurohematopoietic stem-cell population